Alving (1991) J. Immun. Methods 140:1-13.* |
Lockhoff (1991) Angew.Chem.In.Ed.Engl. 30:1611-1620.* |
Gupta et al (1993) Vaccine 11:293-306.* |
Richards et al (1988) Inf. Imm. 56:682-686.* |
Deres et al (1989) Nature 342:561-564.* |
Wiesmüller et al (1989) Vaccine 7:29-33.* |
Nixon-George et al (1990) J. Immunology 144:4798-4802.* |
Durette et al. Carbohydrate Research Vol 108, 1982, p 139-147.* |
Gupta et al. Vaccine 11(3), 1993, p 293-306.* |
Richards et al. Inf and Immunity 56(3), Mar 88, p 682-686.* |
Masihi et al. Int J Immunopharmacol 8(3), 1986, p 339-345.* |
Stunkel et al. Prog Leukocyte Biol 9 (Cell. Basis Immune Modulation), 1989, p 575-579.* |
Penney et al. J Biol Standardization 14(4), 1986, p 345-349.* |
Wiesmueller et al. Vaccine 7(1), 1989, p29-33.* |
Ramasamy et al. J Natn Sci Coun Sri Lanka 21(1), 1993 p 125-140.* |
Vanlandschoot et al., Vaccine vol. 11 issue 12, pp. 1185-1187 “Recombinant secreted haemagglutin protects mice against a lethal challenge of influenza virus”, 1993.* |
Nixon-George et al (1990), J. Immunology 144: 4798-4802. |
Wiesmuller, 1989, Vaccine 8: 29-33. |
Deres et al. (1989), Nature 342: 561. |